Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Substudy of Efficacy, Safety and Toxicology of Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation (ESTxENDS Trial)- the Metabolic Substudy of ESTxENDS

NCT03612336 is registered in ClinicalTrials.gov with University of Bern as lead sponsor.

NCT NCT03612336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03612336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Substudy of Efficacy, Safety and Toxicology of Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation (ESTxENDS Trial)- the Metabolic Substudy of ESTxENDS
Lead sponsor
University of Bern
Phase
Not applicable
Overall status
Completed
Start date
July 16, 2018
Completion date
August 31, 2023
Enrollment
1,246 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, smoking cessation